Sociedad Química y Minera de Chile S.A. (SQM) Earnings Call Transcript
November 19, 2025
Earnings Call Speaker Segments
Hello everyone, and thanks for being on the line for SQM's conference call about our results in the third quarter of 2025; this session is being recorded and streamed live over the web. You can find our earnings press release and the results presentation that goes with it on our website, plus a link to the webcast. Joining us today are Mr. Ricardo Ramos, our Chief Executive Officer; Mr. Gerardo Illanes, our Chief Financial Officer; Mr. Carlos Diaz, who leads the Lithium Chile division as CEO; Mr. Pablo Altimiras, CEO of the Iodine and Plant Nutrition division; and Mr. Mark Fones, CEO of the International Lithium Division; we also have with us colleagues from our commercial and business intelligence teams. On today's call, we have Felipe Smith, who serves as Commercial Vice President of the Lithium Chile division; Pablo Hernandez, Vice President of Strategy and Development for that same Lithium Chile division; Juan Pablo Bellolio, Commercial Vice President of Plant Nutrition and Specialty Products; and Andres Fontannaz, Commercial Vice President of the International Lithium Division. Before we begin, please note that any remarks made during this call regarding our business outlook, future economic performance, anticipated profitability, revenues, expenses, and other financial items, along with expected cost synergies and growth across our product and service lines, are considered forward-looking statements under U.S. federal securities laws. These statements are not historical facts and involve risks and uncertainties that could cause actual results to differ materially. We don't have any duty to revise these remarks, unless the law demands it. If you'd like a full look at our forward-looking statements, our earnings press release and presentation cover that. At this point, I'll turn things over to Mr. Ricardo Ramos, our Chief Executive Officer.
Thanks. Morning, everyone, and I appreciate you being with us today. In Q3, lithium pricing conditions turned out better than what we saw in the prior period. The market is still quite volatile, but we're cautiously optimistic. Our realized average prices went up, and although we anticipate that favorable momentum carrying into Q4, our attention stays on producing high-quality material, serving as a dependable supplier, growing volumes, and pushing forward with our cost reduction efforts. The underlying demand picture is solid, both from EVs and from energy storage systems, which now represent over 20% of worldwide lithium demand. From an operations standpoint, it was an excellent quarter. We achieved record lithium shipment volumes in SQM's history, backed by low costs and strong efficiencies at our Atacama facilities. Our Australian operation kept moving ahead according to plan. Spodumene sales rose considerably. We began lithium hydroxide output, and we hit record sales volumes for spodumene concentrate — a significant milestone for this project; we anticipate commercial activity staying robust during Q4. Beyond the Lithium segment, results were solid as well. In Iodine and Plant Nutrition, performance stayed strong. Iodine prices remain elevated amid a balanced supply-demand backdrop. Our seawater pipeline construction has now passed 80% completion, which allows us to deliver extra iodine to the market sooner than anticipated, should the need arise. We're also growing our iodine production capacity via a third operation being developed in Maria Elena, adding 1,500 tons of iodine capacity. That reinforces our long-term supply position and strengthens our standing as a dependable supplier; in fertilizer, demand remains healthy and prices are stable across most major markets. Our Specialty Plant Nutrition business achieved modest yet sustainable growth versus a year ago, in both volumes and revenues. The move toward tailor-made solutions and higher value blends keeps enhancing our product mix and supports our approach of directing products to the most attractive markets; in iodine, revenues rose 5% year-on-year, with prices averaging near $73 per kilogram. The x-ray contrast media segment — the biggest end-use application — keeps expanding steadily and remains a critical driver of long-term demand; we also finished a thorough review of our CapEx program covering 2025 to 2027. Total CapEx is now projected at $2.7 billion across that 3-year span. Our plan keeps its emphasis on raising production capacity, maintaining low cost, guaranteeing high product quality, and upholding rigorous sustainability standards. Although certain investment decisions have been pushed back, that doesn't impact our capacity to fulfill the production and sales targets established for each of our divisions. Lastly, as SQM and Codelco announced last week, we obtained approval from China's antitrust regulator. We're eager to move this joint venture forward before year-end. Thank you.
Joel, I'll take your questions individually. Could you share your perspective on the current state of lithium demand? Specifically, I was hoping to dig into something: it appears that within China, projections for lithium demand are considerably greater — forecasts originating from Chinese analysts, that is — whereas those from outside China, in the Western world, tend to show lower demand projections. Are you noticing this gap? Does it relate to energy storage in China? Could you address that?
Joe, this is Pablo Hernandez speaking; as for our 2025 demand outlook, we've upgraded it lately compared to our prior earnings call, thanks to EV sales performing better than anticipated, especially across Europe, along with the substantial rise in BSS shipments you brought up. Consequently, we anticipate demand hitting above 1.5 million metric tons during this year, which amounts to growth exceeding 25%. When it comes to China, that country keeps holding a major lead in the EV sector. We projected 30% growth year-on-year, accounting for over 60% of worldwide EV sales. Turning to the other major EV markets, Europe experienced a remarkably robust first 3 quarters this year, with year-over-year growth surpassing 30%. In the U.S., growth remained slower at 10% year-over-year, whereas the rest of the world, naturally, posted impressive figures, achieving 40% year-over-year growth.
Alright. During the previous quarter, you mentioned that your lithium output from Chile would rise roughly 10%, and that your portion at Mt. Holland would come to about — pardon me, 20,000 tons. Do you still stand by that 10% increase compared with the prior year at Atacama? And should we now anticipate a figure nearer to 24,000 or 25,000 tons for the year from Mt. Holland in spodumene?
Joe, it's Gerardo here. So we're clear, are you referring to production or to sales?
So last quarter you told us that Atacama output or sales at the <<inaudible>> would rise 10% for this year, and that Mt. Holland would deliver 20,000 tons. Now in this quarter's release, you're saying Q4 volumes at Mt. Holland will look like Q3, which suggests Mt. Holland would give us more than 20,000 tons. So maybe, what do you figure Atacama will do? What sort of output are you expecting from Chile this year? And what sort of output are you expecting from Australia this year? Let's frame it that way.
Joe, Carlos Diaz here. So our Chilean output is tracking to plan. This year we're looking at producing close to 230,000, and that's lithium out of the Salar de Atacama. Of that, 180,000 gets processed in Chile, while 50,000 will be processed in China, beginning with our lithium sulfate output, which has gone very well for us; we'll keep pushing on expansion for next year, and we're expecting growth next year. We don't yet have the final number, but we're still working to lift output; that covers lithium production in Chile.
Joe, it's Mark Fones here. Regarding the latter portion of what you asked, that's correct — our output estimate, or guidance, for this year stands as is. You might remember it ranged from 150,000 to 170,000 tons of spodumene concentrate at 5.5%; so that remains unchanged. As for the sales figure you brought up — 20,000 tons LCE for this year — you're correct there too; we're raising it to somewhere between 23,000 and 24,000 tons.
Okay, that's great. Then for my final question: if we compare the average selling prices for lithium that you receive in Chile versus internationally, there's roughly a $3,000 to $4,000 per ton discount. Is it right to view that as essentially the conversion costs baked in, since you have to pay a toller to make spodumene on an LCE basis? And should we anticipate that discount on international prices relative to the realized Chilean price narrowing over 2026 as the Kwinana hydroxide conversion plant ramps up?
Joel, it's Andres Fontannaz here. On pricing for the SQM International Lithium division, bear in mind that spodumene accounts for the bulk of what we sell. Over 90% of our third quarter sales came from spodumene. And at present, every sale we report is on a lithium carbonate equivalent basis. So to line those prices up against what we're achieving in the Chilean operation, you have to factor in the conversion factors as well as the refining cost. That would give you a fairer comparison.
Okay, so here's what I want to ask — during 2026, when Kwinana is ramping up, shouldn't the realized price you get internationally, on an LCE basis, move nearer to what Chile gets as Kwinana comes up next year?
Joel, Gerardo here. No need to be concerned — beginning next quarter, or next year, once the product is sold we'll be reporting those figures out of Australia. Whether it's lithium hydroxide or spodumene, the breakdown will be visible to you, so that confusion about prices with or without the conversion cost won't exist.
I trust my voice is coming through clearly. To start, I want to confirm my understanding regarding production in China. Are you currently operating at 50,000 tons there? My recollection is that capacity stood at roughly 30,000 tons, plus the possibility of tolling an additional 20,000. So I'm curious whether additional capacity could be utilized in China next year, assuming market conditions stay as favorable as they are today on the pricing side. Is China operating at full capacity? My second question follows up on the Codelco joint venture. Suppose the signing happens by the end of the year, as Ricardo just mentioned — would SQM owe any kind of retroactive payment for 2025, given how long the contract took to sign? Put differently, when examining the company's free cash flow, even if you consolidate — and you most likely will consolidate the whole thing — should we expect any adjustment effect or cash transfers once the contract is fully signed?
Lucas, this is Ricardo. To begin, you're correct that a dividend must be paid to Codelco next year. That dividend will correspond to the tonnage volume attributed to Codelco under the joint venture agreement; and we will record this amount in our accounting as soon as the agreement is finalized. It — our financial statements have stated very clearly that this must be done as soon as we have the agreement with Codelco; and it is reflected there, and you can work out the figure because the public agreement between SQM and Codelco makes it quite clear.
Carlos Diaz here once more, Lucas. On your initial question about what we make in China, I should start by saying we're looking at roughly 100,000 metric tons of lithium sulfate coming out this year. To put that alongside lithium carbonate and hydroxide, you'd halve it, which lands us at about 50,000. Of that total, 20,000 will come from our own <<inaudible>> facility in China, while 30,000 will be handled through third parties. Looking ahead to the year to come, we anticipate continued growth in lithium sulfate output, and we're currently examining and assessing an expansion of capacity at our own Chinese plant. Such is our plan.
Lucy here, filling in for Ben. Three things from me. Given the reduced CapEx budget and lithium prices beginning to climb, what's the right way to view our financing needs for 2026? Can we reasonably call the base case one with no capital raise?
Lucy, Gerardo speaking. The balance sheet is there for you to look at; it's quite robust, and it has consistently been quite robust; and right now, even with pricing where it stands, a number of our key KPIs are getting better. Keeping a solid investment grade is something we're firmly dedicated to; and we see multiple levers available to us that could be used prior to resorting to the final one, which is a capital raise. So several efforts are underway on our end; and provided our balance sheet stays robust, it might not be necessary.
For my next question — earlier this week, Ganfeng put out a projection of 30% to 40% growth in lithium demand for next year. Any early views from your side on how demand will grow next year? And specifically, what's your outlook for how ESS demand will develop next year?
Lucy, it's Pablo Hernandez speaking. On Ganfeng — naturally, we'll want to dig into what assumptions they used. That said, it does appear to be a solid, optimistic forecast for next year. As for us, when it comes to 2026, we're still working through our demand growth expectations, and we're staying fairly conservative, with a view toward exceeding 1.7 million metric tons. The primary driver will remain EVs, and, as you pointed out, the extremely robust demand we've been seeing on the BSS side.
Great. Last question from me: in 2026, what amount of R&M output increase do you anticipate that won't originate with SQM? And does all of it come from Chile?
This is Pablo Altimiras. So, when it comes to production by third parties — using only what's publicly available to us — our view is that the bulk of it will originate in Chile, from caliche ore. We can't give a precise number, though what we expect is that this quantity won't exceed total demand growth.
Could you bring us up to date on how things are going toward completing the transaction with Codelco, and also walk us through which milestones are still outstanding? If it fails to close before 2025, what occurs? Does a long stop close exist in that situation? What would take place?
Apologies, this is Ricardo. To begin, as we made public, we reached a deal with China's antitrust regulator, which represented the final external approval still required on our side. And at this point, all matters are being examined, in particular the contracts between CORFO and Codelco that fall under review by Contraloria in Chile. Contraloria functions as a sort of internal government audit entity that has to examine contracts of this type. Our expectation is that such review comes back favorable and arrives prior to the year's end. There isn't a second one; we are going to complete this within the year. That is certain.
Excellent. One more thing, if you don't mind; I'd like to ask about the expected 2026 mix coming out of Australia. In 2026, what blend of spodumene and hydroxide do you anticipate from Australia? If you could give some indication regarding that.
Andres, Mark Fones here. Our budget for next year's production at Mt. Holland hasn't been finalized yet. What I can say is that at Mt. Holland, the mine and concentrator should be running at full capacity. Naturally, then, we'd expect 50% of Mt. Holland's capacity when it comes to spodumene concentrate. Regarding the refinery, though, the situation with ramp-up is that, as you're well aware, we announced first product this year, and we'll be increasing production until we get to nearly nameplate capacity by the conclusion of 2026. The precise volume of that lithium hydroxide — taking into account all the solid work covalent has done alongside Wesfarmers and SQM at the refinery, plus every difficulty that comes with any ramp-up in a capital project — will occur next year, and that still isn't clear, so we'll update the market when the appropriate time arrives.
For my first question, I'd appreciate additional detail regarding the CapEx cutback. You brought it down roughly 22% compared with the prior year; however, based on what I read in the press release, you indicated there won't be — no effect on capacity or projects; so I'm unclear how to interpret that. Perhaps you could walk us through the CapEx decrease, which business or segment division it relates to, and any projects that got deferred beyond the 2027 timeframe — that would be useful.
Corinne, it's Gerardo here. Allow me to walk you through what we disclosed. So, as of yesterday, we shared that our CapEx program covering '25 through '27 will come in at roughly $2.7 billion. Breaking that down, approximately $1.3 billion goes to the Lithium Chilean division, where basically the key projects involve completing the lithium hydroxide expansion to hit 100,000 metric tons, which ought to be finished early next year. After that comes the expansion to reach 260,000 metric tons of lithium carbonate capacity in Chile, while we continue pursuing initiatives to keep producing lithium sulfate, which is quite important, as Carlos mentioned earlier. Turning to the International Lithium division, the overall CapEx contained within that $2.7 billion is roughly $700 million, and that figure includes about $400 million split between the Mt. Holland expansion and the initial stages of Azure. Naturally, both of those projects still need approval from our partners, but that's what falls within this period; and lastly, for the Iodine and Plant Nutrition business line, total CapEx comes to approximately $800 million. That covers the seawater pipeline, which ought to be completed next year and will be essential for giving us flexibility to produce additional iodine, plus the Maria Elena iodine production site, which should enable us to add more iodine production or capacity starting now.
Perhaps for my second question, I'd like to return to the Codelco agreement. Is it still the case that you're awaiting the local group's coming together? If that's right, could you give us an update on where things stand with them?
No, no, no. Sorry. When it comes to the communities, we reached an agreement with them — I believe that happened a couple of months ago. It was made public that we had reached the final agreement so that we could move forward; and the sole party that has already been described to you is the government's internal auditing body, which is examining the agreements between CORFO and Codelco. And once their review and their approval are complete, we will proceed with the joint venture start-up.
If I could just ask something quickly as a follow-up. When you were talking about what you expect from demand — I believe 25% growth up to 1.5 million tons came up. My uncertainty was whether that applies to 2025 or to 2026, since the presentation had you citing 20% as the expectation for demand growth in '25. Could you also go into how demand looks for 2026? Beyond that, some additional color on ESS demand would be great — that's the market potential people have been talking about these past few weeks. After that, I've got a few more follow-ups too.
Marcio, Gerardo here. Let me take a second before I get to your question. Also, one clarification on what I said earlier. I brought up 260,000 metric tons of lithium production — that's lithium carbonate production capacity located in Chile, though what it actually refers to is 600 — excuse me, 260,000 metric tons of lithium production in total, sourced from Chile out of lithium chlorine, or tolled in China from lithium sulfate.
Marcio, Pablo Hernandez here. Regarding what you asked — the figure I gave earlier of 1.5 million metric tons, meaning more than 1.5 million metric tons alongside that 25% year-over-year increase, pertained to 2025. And, as I stated as well, for 2026 we anticipate that figure will climb past 1.7 million metric tons. Turning specifically to BSS, just as you correctly pointed out, and as has come up during this call, demand from BSS has grown strongly, and we put that at somewhere between 40% and 50% year-over-year growth for this year, with those levels expected to hold steady in the following year too.
That sounds excellent. Perhaps one more question related to the Codelco transaction. Could you share what the expectations are regarding — you'd likely require a revision of your offer license should you proceed with the intention of generating close to 260,000 tons in total from Chilean assets. Clearly, ideally, you would want to postpone as much CapEx as you can until the JV takes effect in 2030. So I'm wondering whether any CapEx tied to Salar Futuro might be spent prior to 2030? Or is it possible to push that past 2030, once the JV becomes effective? That would be wonderful.
All right. To begin, the agreement takes effect on the very day we signed it, which is going to occur within the coming weeks. I certainly hope so; and once we've signed that agreement — we signed with Codelco — the agreement begins. There's no need to hold off until 2030. That said, you're correct that Salar Futuro is a truly tremendous project, and we're putting in a lot of hard work on it. Our plan is to deliver the environmental study to the authorities and communities sometime next year. It will be a complicated project, and in all likelihood we'll finalize the agreement sometime in 2029, 2030, which means the initial investment in Salar Futuro — a large project and a highly compelling one — will begin in 2030 or 2031. This means it won't impact CapEx over the coming 3 or 4 years. It won't impact 2026, '27, '28, and we'll keep going with our current project plan at the Salar de Atacama as we always have. That's the reason this project will deliver a meaningful impact — yes, and a very favorable one — beginning, I hope, in 2030, or if not, 2031.
That sounds good. Perhaps a final question regarding iodine. Clearly, the market has been robust for a few years at this point. I believe roughly 5,000 tons of capacity will be introduced by you once the new pipeline alongside Maria Elena is operational; so could you discuss a bit the general supply and demand situation for iodine, and whether you think prices above $70 per ton, or $70 per kilo, can stay sustainable? Which other places might see supply expansion that could create some downward pressure on prices, if any, over the coming few years?
This is Pablo Altimiras. Well, as has been stated previously, supply and demand during this year is tight since we — in this year, no extra supply is appearing. In fact, demand this year isn't expanding owing to insufficient supply. We think demand next year is going to increase somewhere around 3%; and what's the reason demand will increase? Since we observe additional capacity reaching the market next year. Like I mentioned earlier, that's primarily originating from caliche ore. Thus we think additional supply will be available next year.
My first question is this: suppose lithium hydroxide and spodumene prices remain roughly where they sit today through 2026 — would Kwinana conversion, on a stand-alone basis, be profitable?
Mazahir, Mark Fones here. Yes. We have noted previously that we keep viewing the longer-term profitability of Kwinana along with the Mt. Holland project as positive. We also remain committed alongside our partners, and we will carry on developing this project. That is likewise why we announced our expectation of a final investment decision next year on the expansion for the mining concentrator.
All right, and I might ask one more thing regarding the Codelco arrangement. Concerning those 201 kilotons of lithium credited to Codelco, am I right in thinking that payment will come in the form of revenue tied to that quantity of lithium? Or does it fall under gross profit? Or perhaps it's based on a different measure entirely?
Gerardo here. Correct — what gets paid to Codelco is determined by a set tonnage each year, namely 33.5, and it's delivered in the form of a dividend.
Yeah, one thing I'd like to get straight — will this figure come from the revenue tied to 33.5 kilotons, or from the gross profit tied to that quantity of lithium?
What we're talking about is the profitability generated by this tonnage, though the precise math and the precise method for arriving at that figure are laid out in the contracts anyone can view publicly on our website.
We appreciate it. That brings us to the end of today's conference call. Thanks for joining us. You're free to disconnect at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Sociedad Química y Minera de Chile S.A. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Sociedad Química y Minera de Chile S.A. earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.